| [1] |
Berr CM, Di Dalmazi G, Osswald A, et al. Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology[J]. J Clin Endocrinol Metab, 2015, 100(4): 1300-1308. DOI: 10.1210/jc.2014-3632.
|
| [2] |
|
| [3] |
|
| [4] |
Di Dalmazi G, Berr CM, Fassnacht M, et al. Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: a systematic review of the literature[J]. J Clin Endocrinol Metab, 2014, 99(8): 2637-2645. DOI: 10.1210/jc.2014-1401.
|
| [5] |
Kohler S, Karavitaki N, Wass JAH. Post-operative replacement and assessment of HPA axis recovery in Cushing's syndrome[M]// Bronstein MD. Cushing's Syndrome: Pathophysiology, Diagnosis and Treatment. Totowa, NJ: Humana Press, 2011: 249-258. DOI: 10.1007/978-1-60327-449-4_20.
|
| [6] |
Balasko A, Zibar Tomsic K, Kastelan D, et al. Hypothalamic-pituitary-adrenal axis recovery after treatment of Cushing's syndrome[J]. J Neuroendocrinol, 2022, 34(8): e13172. DOI: 10.1111/jne.13172.
|
| [7] |
Dineen R, Martin-Grace J, Thompson CJ, et al. The management of glucocorticoid deficiency: Current and future perspectives[J]. Clin Chim Acta, 2020, 505: 148-159. DOI: 10.1016/j.cca.2020.03.006.
|
| [8] |
Cui Q, Liu D, Xiang B, et al. Morning serum cortisol as a predictor for the HPA axis recovery in Cushing's disease[J]. Int J Endocrinol, 2021, 2021: 4586229. DOI: 10.1155/2021/4586229.
|
| [9] |
Scherholz ML, Schlesinger N, Androulakis IP. Chronopharmacology of glucocorticoids[J]. Adv Drug Deliv Rev, 2019, 151-152: 245-261. DOI: 10.1016/j.addr.2019.02.004.
|
| [10] |
Tang K, Wang L, Yang Z, et al. Comparison of hydrocortisone and prednisone in the glucocorticoid replacement therapy post-adrenalectomy of Cushing’s Syndrome[J]. Oncotarget, 2017, 8(62): 106113-106120. DOI: 10.18632/oncotarget.20597.
|
| [11] |
|
| [12] |
Fujii K, Miyashita K, Kurihara I, et al. Adrenal insufficiency under standard dosage of glucocorticoid replacement after unilateral adrenalectomy for Cushing's syndrome[J]. Case Rep Endocrinol, 2016, 2016(1): 2347528. DOI: 10.1155/2016/2347528.
|
| [13] |
McGlotten R, Nieman LK. MON-167 use of a morning Cortisol level to predict recovery of the hypothalamic-pituitary-adrenal (HPA) axis in secondary adrenal insufficiency following remission of Cushing's syndrome[J]. J Endocr Soc, 2020, 4(Supplement_1): MON-167. DOI: 10.1210/jendso/bvaa046.616.
|
| [14] |
Zhang CD, Ioachimescu AG. Challenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome[J]. Front Endocrinol, 2024, 15: 1353543. DOI: 10.3389/fendo.2024.1353543.
|
| [15] |
Polovina TS, Kraljevic I, Solak M, et al. Early basal Cortisol level as a predictor of hypothalamic-pituitary-adrenal (HPA) axis function after pituitary tumor surgery[J]. Exp clin Endocrinol Diabetes, 2020, 128(11): 709-714. DOI: 10.1055/a-0885-1568.
|
| [16] |
Pilon A, Laudat A. Exploration biochimique de la corticosurrénale[J]. Rev Francophone Des Laboratoires, 2022, 2022(544): 26-35. DOI: 10.1016/S1773-035X(22)00246-5.
|
| [17] |
Martin-Grace J, Tomkins M, O'Reilly MW, et al. Iatrogenic adrenal insufficiency in adults[J]. Nat Rev Endocrinol, 2024, 20(4): 209-227. DOI: 10.1038/s41574-023-00929-x.
|
| [18] |
Filipsson H, Monson JP, Koltowska-Häggström M, et al. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients[J]. J Clin Endocrinol Metab, 2006, 91(10): 3954-3961. DOI: 10.1210/jc.2006-0524.
|
| [19] |
Asuzu DT, Bhatt S, Nwokoye D, et al. Cortisol and ACTH measurements at extubation from pituitary surgery predicts hypothalamic-pituitary-adrenal axis function[J]. J Endocr Soc, 2023, 7(4): bvad025. DOI: 10.1210/jendso/bvad025.
|
| [20] |
Suliman AM, Freaney R, Smith TP, et al. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency[J]. Clin Endocrinol, 2003, 59(3): 380-387. DOI: 10.1046/j.1365-2265.2003.01860.x.
|
| [21] |
Falcetta P, Orsolini F, Benelli E, et al. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study[J]. Endocrine, 2021, 71(1): 178-188. DOI: 10.1007/s12020-020-02476-1.
|
| [22] |
Neumann U, Braune K, Whitaker MJ, et al. A prospective study of children aged 0-8 years with CAH and adrenal insufficiency treated with hydrocortisone granules[J]. J Clin Endocrinol Metab, 2021, 106(3): e1433-e1440. DOI: 10.1210/clinem/dgaa626.
|
| [23] |
Mittal M, Jain V. Management of obesity and its complications in children and adolescents[J]. Indian J Pediatr, 2021, 88(12): 1222-1234. DOI: 10.1007/s12098-021-03913-3.
|
| [24] |
Tatsi C, Stratakis CA. Pediatric Cushing syndrome; an overview. Pediatr Endocrinol Rev. 2019, 17(2): 100-109. DOI: 10.17458/per.vol17.2019.
|
| [25] |
Sugawara H, Wada N, Baba S, et al. A case of Cushing's syndrome in a pregnant woman associated with hypertension, hypokalemia, and gestational diabetes mellitus[J]. Diabetol Int, 2024, 15(4): 845-849. DOI: 10.1007/s13340-024-00745-2.
|
| [26] |
Jin M, Xu H. The treatment of gestational diabetes mellitus[J]. J Biosci Med, 2023, 11(4): 407-416. DOI: 10.4236/jbm.2023.114029.
|
| [27] |
Deitch JM, Lee IL, Yates CJ, et al. Simplified gestational diabetes screening with a triaging fasting plasma glucose reduces the burden of oral glucose tolerance tests during pregnancy-A large tertiary comparative cohort study[J]. Diabetes Res Clin Pract, 2024, 209: 111120. DOI: 10.1016/j.diabres.2024.111120.
|
| [28] |
Dineen R, Behan LA, Kelleher G, et al. The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy[J]. BMC Endocr Disord, 2020, 20(1): 154. DOI: 10.1186/s12902-020-00633-1.
|
| [29] |
|
| [30] |
Limbachia V, Nunney I, Page DJ, et al. The effect of different types of oral or intravenous corticosteroids on capillary blood glucose levels in hospitalized inpatients with and without diabetes[J]. Clin Ther, 2024, 46(2): e59-e63. DOI: 10.1016/j.clinthera.2023.11.013.
|
| [31] |
Beuschlein F, Else T, Bancos I, et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol Metab. 2024, 109(7): 1657-1683. DOI: 10.1210/clinem/dgae250.
|
| [32] |
Aulinas A, Valassi E, Webb SM. Prognosis of patients treated for Cushing syndrome[J]. Endocrinol Nutr, 2014, 61(1): 52-61. DOI: 10.1016/j.endonu.2013.03.008.
|